MedTrace Logo

A Study In Patients With Type 2 Diabetes Mellitus

NCT00256867 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 369

Last updated 2018-07-02

Study results available
· View outcomes & findings →

Summary

This study evaluates the effect of medicines for type 2 diabetes and lipids control. This study will require about 6 office visits for lab tests and examinations. All study related medicines and medical examinations will be provided at no cost to the subjects.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

GSK523338

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-18
Primary Completion
2006-10-31
Completion
2006-10-31

Countries

  • United States
  • Australia
  • Canada
  • Mexico
  • Philippines
  • Puerto Rico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00256867 on ClinicalTrials.gov